Kiniksa Pharmaceuticals International
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell KNSA and other ETFs, options, and stocks.About KNSA
Kiniksa Pharmaceuticals International Plc is a commercial-stage biopharmaceutical company. It engages in discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases with significant unmet medical need.
CEOSanj K. Patel
CEOSanj K. Patel
Employees315
Employees315
HeadquartersLondon, Greater London
HeadquartersLondon, Greater London
Founded2024
Founded2024
Employees315
Employees315
KNSA Key Statistics
Market cap2.12B
Market cap2.12B
Price-Earnings ratio-118.78
Price-Earnings ratio-118.78
Dividend yield—
Dividend yield—
Average volume539.81K
Average volume539.81K
High today$29.58
High today$29.58
Low today$28.83
Low today$28.83
Open price$29.03
Open price$29.03
Volume517.85K
Volume517.85K
52 Week high$30.69
52 Week high$30.69
52 Week low$17.82
52 Week low$17.82
Analyst ratings
100%
of 6 ratingsBuy
100%
Hold
0%
Sell
0%
People also own
Based on the portfolios of people who own KNSA. This list is generated using Robinhood data, and it’s not a recommendation.